Detalhe da pesquisa
1.
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Nature
; 592(7854): 463-468, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762734
2.
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection.
J Neurooncol
; 167(1): 155-167, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358406
3.
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
J Neurooncol
; 167(1): 133-144, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326661
4.
Robust methylation-based classification of brain tumours using nanopore sequencing.
Neuropathol Appl Neurobiol
; 49(1): e12856, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269599
5.
Clinical implementation of a 3D4K-exoscope (Orbeye) in microneurosurgery.
Neurosurg Rev
; 45(1): 627-635, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142267
6.
Augmented reality visualization in brain lesions: a prospective randomized controlled evaluation of its potential and current limitations in navigated microneurosurgery.
Acta Neurochir (Wien)
; 164(1): 3-14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904183
7.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782343
8.
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.
Acta Neuropathol
; 140(6): 893-906, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926213
9.
Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
J Neurooncol
; 146(2): 347-355, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900826
10.
T2 mapping of molecular subtypes of WHO grade II/III gliomas.
BMC Neurol
; 20(1): 8, 2020 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914945
11.
Monitor-based exoscopic 3D4k neurosurgical interventions: a two-phase prospective-randomized clinical evaluation of a novel hybrid device.
Acta Neurochir (Wien)
; 162(12): 2949-2961, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424568
12.
Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report.
Neuropathol Appl Neurobiol
; 49(1): e12859, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332636
13.
Acceptance and compliance of TTFields treatment among high grade glioma patients.
J Neurooncol
; 139(1): 177-184, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29644485
14.
(18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors.
Childs Nerv Syst
; 31(2): 261-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25231277
15.
Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status.
Cell Rep Med
; 4(1): 100877, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584682
16.
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas.
J Neurooncol
; 109(1): 15-22, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22528790
17.
Correlation of Tumor Pathology with Fluorescein Uptake and MRI Contrast-Enhancement in Stereotactic Biopsies.
J Clin Med
; 11(12)2022 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743401
18.
MRI-Based Risk Assessment for Incomplete Resection of Brain Metastases.
Front Oncol
; 12: 873175, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35651793
19.
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
Int J Radiat Oncol Biol Phys
; 112(5): 1269-1278, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963556
20.
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.
Neurol Res Pract
; 4(1): 20, 2022 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599302